HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID‐19

Author:

Castro‐Santos Patricia12,Rojas‐Martinez Augusto3,Riancho José A.456,Lapunzina Pablo789,Flores Carlos10111213,Carracedo Ángel1714,Díaz‐Peña Roberto12ORCID,

Affiliation:

1. Fundación Pública Galega de Medicina Xenómica (SERGAS), Centro Nacional de Genotipado Health Research Institute of Santiago de Compostela (IDIS) Santiago de Compostela Spain

2. Faculty of Health Sciences Universidad Autónoma de Chile Talca Chile

3. Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud Monterrey Mexico

4. IDIVAL Cantabria Spain

5. Universidad de Cantabria Cantabria Spain

6. Hospital U M Valdecilla Cantabria Spain

7. Centre for Biomedical Network Research on Rare Diseases (CIBERER) Instituto de Salud Carlos III Madrid Spain

8. Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz‐IDIPAZ Madrid Spain

9. ERN‐ITHACA‐European Reference Network Paris France

10. Genomics Division Instituto Tecnológico y de Energías Renovables (ITER) Santa Cruz de Tenerife Spain

11. Research Unit Hospital Universitario Nuestra Señora de Candelaria Santa Cruz de Tenerife Spain

12. CIBER de Enfermedades Respiratorias (CIBERES) Instituto de Salud Carlos III Madrid Spain

13. Faculty of Health Sciences University of Fernando Pessoa Canarias Las Palmas de Gran Canaria Spain

14. Grupo de Medicina Xenómica‐CIMUS‐Universidade de Santiago de Compostela Santiago de Compostela Spain

Abstract

We analyzed the association between HLA polymorphisms and susceptibility to SARS‐CoV‐2 infection and disease severity. Genotyping data from a total of 9373 COVID‐19‐positive cases from the Spanish Coalition to Unlock Research on Host Genetics on COVID‐19 (SCOURGE) consortium and 5943 population controls were included in the study. We found an association of the alleles HLA‐B*14:02 and HLA‐C*08:02 with a lower risk to COVID‐19 infection (p = 0.006, OR = 0.84, 95% CI = [0.75–0.95], p = 0.024, OR = 0.86, 95% CI = [0.78–0.95], respectively). We also found the alleles HLA‐A*11:01 and HLA‐C*04:01 associated with disease severity (p = 0.033, OR = 1.16, 95% CI = [1.04–1.31], p = 0.045, OR = 1.14, 95% CI = [1.05–1.25], respectively). These results suggest that an effective presentation of viral peptides by HLA class I alleles involve a faster infection clearance, decreasing the susceptibility and severity of COVID‐19.

Funder

Instituto de Salud Carlos III

European Regional Development Fund

Publisher

Wiley

Subject

Genetics,Immunology,Immunology and Allergy

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3